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Journal of Clinical Epidemiology 105 (2019) 147e148LETTERS TO THE EDITORLetter re: Christiansen DH, de Vos Andersen
N-B, Poulsen PH, Ostelo RW, The smallest
worthwhile effect of primary care physiotherapy
did not differ across musculoskeletal pain sites,
Journal of clinical epidemiology (2018), doi:
10.1016/j.jclinepi.2018.05.019We read with great interest the recent paper titled ‘‘The
smallest worthwhile effect of primary care physiotherapy
did not differ across musculoskeletal pain sites.’’ We
commend the authors for investigating this important topic
and believe this paper makes very useful contributions. We
agree that the widely used anchor or distribution-based
methods for obtaining clinically important effect estimates
are flawed. The approach of investigating smallest worth-
while effects (SWEs) using the benefiteharm trade-off is,
in our opinion, a more valid approach. We do, however,
have concerns that small sections of the manuscript are
not consistent with the study findings and could easily
lead to important misinterpretations.
A key finding of the present study was that the median
SWE was 20% (IQR 10%e30%). To correctly interpret
this, it is critical to distinguish between a 20% relative differ-
ence and a 20% absolute difference. Randomized controlled
trials of musculoskeletal conditions commonly report base-
line scores of approximately 5 on a 0 to 10 pain scale. If nat-
ural recoverywas 30% (as in this study), painwould reduce to
3.5/10. A further 20% relative reduction (using the baseline
5/10 score) would be a 1-point reduction to 2.5/10. In
contrast, an absolute reduction of 20% of the scale would
be 2 points, which is twice as large. It is clear from the
methods that participants were answering in terms of relative
reductions not absolute reductions.
Most of the paper refers to 20% additional improvement,
but it is unclear whether this is relative or absolute. However,
in the discussion, the authors write ‘‘Our results suggest that
patients need to see a reduction in pain and disability equiv-
alent to 20 points on a 100-point scale to perceive that the ef-
fect of Physiotherapy is worthwhile.’’ In our opinion, this is
an incorrect conclusion with important implications. This
statement uses an absolute 20-point reduction, rather than a
20% relative reduction based on the person’s pain or
disability. Many physiotherapy trials demonstrate effects of
approximately 1 point on a 10-point scale. IncorrectlyDOI of original article: https://doi.org/10.1016/j.jclinepi.2018.05.019.
Conflicts of interest: The authors declare that they have no conflicts of
interest.
0895-4356/ 2018 Elsevier Inc. All rights reserved.interpreting the present study’s findings as absolute rather
than relative differences would change the conclusion of
many physiotherapy trials from producing clinically impor-
tant effects to nonclinically important effects.
A second point is to emphasize that this study’s results
are generalizable only to trials comparing physiotherapy
interventions to natural recovery with no treatment. When
comparing two active interventions with similar costs, risks
and harms (e.g., two different exercise interventions), the
SWE of 20% should not be used. A smaller effect would
logically seem clinically important. Similarly, when
comparing physiotherapy to a more expensive intervention
with greater risks (e.g., surgery), the 20% SWE would be
incorrect. This may seem obvious, but there are numerous
examples in the literature where the same values for clinical
importance are used despite very different comparisons. The
same mistake should not be made using the SWE approach,
and by definition, the benefiteharm trade-off approach
should overcome this problem, if interpreted correctly.
We look forward to further work from the authors and
others providing estimates of SWE for a range of different
clinical comparisons.
Mark J. Hancock*
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https://doi.org/10.1016/j.jclinepi.2018.08.009Reply to Hancock and Kent. Clinical important
differences: a step toward a more
intervention-specific approachWe thank Hancock and Kent for their letter [1]. We
agree with them that the smallest worthwhile effect
(SWE) estimates might be prone to erroneousDOI of original article: https://doi.org/10.1016/j.jclinepi.2018.08.009.
Conflict of interest: None.
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provide a more in-depth discussion of our study results.
Indeed, the key finding of our study is that the median
SWE was 20% (IQR 10%e30%) [2]. The interpretation
of this figure should take into account our method of esti-
mating the SWE. For this estimation we used the scripts
as presented in Appendix A. There, we very specifically
ask ‘‘how much additional improvement physiotherapy
must have on your pain and the limitations they impose
on you in your daily life.’’ This clearly illustrates that
the participants were asked to depart from their situation,
that is, to depart from their current level of pain and lim-
itations. So, in the terminology used by Hancock and
Kent, it is a relative reduction as it departs from the base-
line score.
We appreciate the example presented where the
percentage scores are transformed into scale points.
However, we also think this might be potentially
misleading. They use the baseline score of 5 (on a
0e10 numeric rating scale [NRS]), as an example, and
then indeed a 20% reduction would mean a 1-point
reduction (from baseline). But stressing the magnitude
in terms of points on a scale may lead to the erroneous
interpretation that our study suggests that a 1-point extra
reduction on the NRS scale is the between-group differ-
ence which patients consider to be worthwhile. In our
scripts we did not use any specific measurement instru-
ment. This means that the 20% additional improvement
patients consider being worthwhile results in different
scale points for different patients (i.e., for a
baseline NRS score of 8, it is 1.6; for a baseline NRS
score of 5, it is 1). Therefore, we propose that the
SWE is not transformed into scale points in this way,
but rather that is used as intended. That is, for every pa-
tient, the percentage of reduction should be calculated
and then, in a randomized controlled trial, the percent-
ages of the treatment arms can be compared, using
the SWE as a guideline for the interpretation of this
between-group difference (i.e., percentage point
difference).
Finally, we fully agree that the SWE we present has to
be interpreted within the context of this study. The
contextual factors are key issues in the SWE
method; and therefore benefits, harms, costs, and incon-
veniences are included in the scripts that we used to elicit
the SWE. Therefore the SWE should not be evaluated
without a comparator condition (e.g., no treatment) and
should include references to the costs, risks, and incon-
veniences of the specific intervention. The expectation
is that, among patients who seek treatment for musculo-
skeletal pain, different estimates would be elicited fordifferent therapies, and we believe our study is an impor-
tant step toward that direction. To what extent the
between-group differences as estimated by the SWE
are really different for various comparisons (e.g., exer-
cise vs. surgery; exercise vs. medication) should be
explored in more detail.
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